125 related articles for article (PubMed ID: 347110)
1. High- and low-potency neuroleptics in elderly psychiatric patients.
Branchey MH; Lee JH; Amin R; Simpson GM
JAMA; 1978 May; 239(18):1860-2. PubMed ID: 347110
[TBL] [Abstract][Full Text] [Related]
2. Drug treatment in newly admitted schizophrenic patients.
Clark ML; Huber WK; Charalampous KD; Serafetinides EA; Trousdale W; Colmore JP
Arch Gen Psychiatry; 1971 Nov; 25(5):404-9. PubMed ID: 4943915
[No Abstract] [Full Text] [Related]
3. Clinical comparison of thiothixene and thioridazine in schizophrenic adolescents.
Realmuto GM; Erickson WD; Yellin AM; Hopwood JH; Greenberg LM
Am J Psychiatry; 1984 Mar; 141(3):440-2. PubMed ID: 6367494
[TBL] [Abstract][Full Text] [Related]
4. Fluphenazine-induced neuroleptic malignant syndrome in a schizophrenic patient.
Aruna AS; Murungi JH
Ann Pharmacother; 2005 Jun; 39(6):1131-5. PubMed ID: 15840734
[TBL] [Abstract][Full Text] [Related]
5. Schizophrenic subtypes defined by response to drugs and placebo.
Goldberg SC; Mattsson NB
Dis Nerv Syst; 1968 May; 29(5):Suppl:153-8. PubMed ID: 4876985
[No Abstract] [Full Text] [Related]
6. An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
Kong DS; Yeo SH
Pharmatherapeutica; 1989; 5(6):371-9. PubMed ID: 2687894
[TBL] [Abstract][Full Text] [Related]
7. Dopamine antagonism by thioridazine in schizophrenia.
Meltzer HY; Sachar EJ; Frantz AG
Biol Psychiatry; 1975 Feb; 10(1):53-7. PubMed ID: 1120175
[TBL] [Abstract][Full Text] [Related]
8. Low serum neuroleptic levels predict relapse in schizophrenic patients.
Brown WA; Laughren T; Chisholm E; Williams BW
Arch Gen Psychiatry; 1982 Sep; 39(9):998-1000. PubMed ID: 6126172
[TBL] [Abstract][Full Text] [Related]
9. [Neuroleptic infusion therapy with high-dosed fluphenazine (author's transl)].
Fünfgeld EW; Kulhanek F
Arzneimittelforschung; 1978; 28(9):1489-91. PubMed ID: 383096
[TBL] [Abstract][Full Text] [Related]
10. Clinical and toxicological profile of fluphenazine decanoate in elderly chronic schizophrenia.
Altamura AC; Mauri MC; Girardi T; Panetta B
Int J Clin Pharmacol Res; 1990; 10(4):223-8. PubMed ID: 2079381
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced dystonia.
Swett C
Am J Psychiatry; 1975 May; 132(5):532-4. PubMed ID: 1119613
[TBL] [Abstract][Full Text] [Related]
12. Fluphenazine enanthate and fluphenazine decanoate in the treatment of schizophrenic outpatients: extrapyramidal symptoms and therapeutic effect.
Chouinard G; Annable L; Ross-Chouinard A
Am J Psychiatry; 1982 Mar; 139(3):312-8. PubMed ID: 6120655
[No Abstract] [Full Text] [Related]
13. [Evaluation of the incidence of tardive dyskinesias in 3 groups of patients treated with different neuroleptics].
Barcia D; Pozo P; Ruiz ME; Forcadell F; Morcillo L; Soria JM; Carrasco E
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1987; 15(1):25-8. PubMed ID: 3577874
[No Abstract] [Full Text] [Related]
14. A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.
Wistedt B
Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():15-23. PubMed ID: 3549878
[TBL] [Abstract][Full Text] [Related]
15. Motility, Parkinsonism, and prolactin with thiothixene and thioridazine.
Crowley TJ; Hydinger-Macdonald M
Arch Gen Psychiatry; 1981 Jun; 38(6):668-75. PubMed ID: 7247630
[TBL] [Abstract][Full Text] [Related]
16. A double blind comparative study of remoxipride and thioridazine in the acute phase of schizophrenia.
McCreadie RG; Todd N; Livingston M; Eccleston D; Watt JA; Tait D; Crocket G; Mitchell MJ; Huitfeldt B
Acta Psychiatr Scand; 1988 Jul; 78(1):49-56. PubMed ID: 2972165
[TBL] [Abstract][Full Text] [Related]
17. Relation of plasma fluphenazine levels to treatment response and extrapyramidal side effects in first-episode schizophrenic patients.
Koreen AR; Lieberman J; Alvir J; Chakos M; Loebel A; Cooper T; Kane J
Am J Psychiatry; 1994 Jan; 151(1):35-9. PubMed ID: 8267132
[TBL] [Abstract][Full Text] [Related]
18. Are antipsychotic drugs interchangeable?
Gardos G
J Nerv Ment Dis; 1974 Nov; 159(5):343-8. PubMed ID: 4612111
[No Abstract] [Full Text] [Related]
19. Implications of phenothiazine side effects: a study of antiparkinsonian agents in an older population.
Martin IC
Acta Psychiatr Scand; 1975 Feb; 51(2):110-8. PubMed ID: 235189
[TBL] [Abstract][Full Text] [Related]
20. Dissimilar dosing with high-potency and low-potency neuroleptics.
Baldessarini RJ; Katz B; Cotton P
Am J Psychiatry; 1984 Jun; 141(6):748-52. PubMed ID: 6145357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
